MedTrace Logo

A LAparoscopic and TransAnal Total Mesorectal Excision (TME) for Rectal Cancer Trial

NCT02324556 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2020-04-28

No results posted yet for this study

Summary

All patients planned for an anterior resection due to rectal cancer with a total mesorectal excision are included. This is a feasibility study, thus no randomization will be performed.

Primary endpoint is clinical and pathologic examination of the specimen. Secondary end-points include clinical variables such as conversion rate, re-admission and/or re-operation due to any complication and health economy analyses.

Conditions

  • Colorectal Neoplasm

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Eva Angenete, M.D., Ph.D. · Sahlgrenska Universitetssjukhuset/Östra

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02324556 on ClinicalTrials.gov